These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Genetic influence of apolipoprotein E4 genotype on hippocampal morphometry: An N = 725 surface-based Alzheimer's disease neuroimaging initiative study. Shi J; Leporé N; Gutman BA; Thompson PM; Baxter LC; Caselli RJ; Wang Y; Hum Brain Mapp; 2014 Aug; 35(8):3903-18. PubMed ID: 24453132 [TBL] [Abstract][Full Text] [Related]
4. Associations of Pulse and Blood Pressure with Hippocampal Volume by APOE and Cognitive Phenotype: The Alzheimer's Disease Neuroimaging Initiative (ADNI). Ngwa JS; Fungwe TV; Ntekim O; Allard JS; Johnson SM; Castor C; Graham L; Nadarajah S; Gillum RF; Obisesan TO; Dement Geriatr Cogn Disord; 2018; 45(1-2):66-78. PubMed ID: 29694964 [TBL] [Abstract][Full Text] [Related]
5. The effect of TOMM40 on spatial navigation in amnestic mild cognitive impairment. Laczó J; Andel R; Vyhnalek M; Matoska V; Kaplan V; Nedelska Z; Lerch O; Gazova I; Moffat SD; Hort J Neurobiol Aging; 2015 Jun; 36(6):2024-33. PubMed ID: 25862420 [TBL] [Abstract][Full Text] [Related]
6. Sex differences in the association of APOE ε4 genotype with longitudinal hippocampal atrophy in cognitively normal older people. Shen S; Zhou W; Chen X; Zhang J; Eur J Neurol; 2019 Nov; 26(11):1362-1369. PubMed ID: 31102429 [TBL] [Abstract][Full Text] [Related]
7. APOE ε4 is associated with disproportionate progressive hippocampal atrophy in AD. Manning EN; Barnes J; Cash DM; Bartlett JW; Leung KK; Ourselin S; Fox NC; PLoS One; 2014; 9(5):e97608. PubMed ID: 24878738 [TBL] [Abstract][Full Text] [Related]
9. Protective effect of apolipoprotein E epsilon 3 on sporadic Alzheimer's disease in the Chinese population: a meta-analysis. Chen Q; Wang T; Kang D; Chen L Sci Rep; 2022 Aug; 12(1):13620. PubMed ID: 35948759 [TBL] [Abstract][Full Text] [Related]
10. Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease. Potkin SG; Guffanti G; Lakatos A; Turner JA; Kruggel F; Fallon JH; Saykin AJ; Orro A; Lupoli S; Salvi E; Weiner M; Macciardi F; PLoS One; 2009 Aug; 4(8):e6501. PubMed ID: 19668339 [TBL] [Abstract][Full Text] [Related]
12. Gender, apolipoprotein E genotype, and mesial temporal atrophy: 2-year follow-up in patients with stable mild cognitive impairment and with progression from mild cognitive impairment to Alzheimer's disease. Spampinato MV; Langdon BR; Patrick KE; Parker RO; Collins H; Pravata' E; Neuroradiology; 2016 Nov; 58(11):1143-1151. PubMed ID: 27590747 [TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E polymorphisms in adults over 60 years of age with mild cognitive impairment and Alzheimer’s disease in different Venezuelan populations. Martínez S; Ochoa B; Pérez MR; Torrico F; García I; Garcia CC Biomedica; 2022 May; 42(Sp. 1):116-129. PubMed ID: 35866735 [TBL] [Abstract][Full Text] [Related]
14. APOE ε4/ε4 homozygotes with early Alzheimer's disease show accelerated hippocampal atrophy and cortical thinning that correlates with cognitive decline. Abushakra S; Porsteinsson AP; Sabbagh M; Bracoud L; Schaerer J; Power A; Hey JA; Scott D; Suhy J; Tolar M; Alzheimers Dement (N Y); 2020; 6(1):e12117. PubMed ID: 33304988 [TBL] [Abstract][Full Text] [Related]
15. Genetic study of multimodal imaging Alzheimer's disease progression score implicates novel loci. Scelsi MA; Khan RR; Lorenzi M; Christopher L; Greicius MD; Schott JM; Ourselin S; Altmann A Brain; 2018 Jul; 141(7):2167-2180. PubMed ID: 29860282 [TBL] [Abstract][Full Text] [Related]